loadpatents
Patent applications and USPTO patent grants for Beshore; Douglas C..The latest application filed is for "fused heteroaryl derivatives as orexin receptor antagonists".
Patent | Date |
---|---|
Fused heteroaryl derivatives as orexin receptor antagonists Grant 10,526,336 - Kuduk , et al. J | 2020-01-07 |
Fused Heteroaryl Derivatives As Orexin Receptor Antagonists App 20180370973 - Kuduk; Scott D. ;   et al. | 2018-12-27 |
TRKA kinase inhibitors, compositions and methods thereof Grant 9,862,716 - Mitchell , et al. January 9, 2 | 2018-01-09 |
Oxazole orexin receptor antagonists Grant 9,828,368 - Liverton , et al. November 28, 2 | 2017-11-28 |
Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators Grant 9,708,273 - Kuduk , et al. July 18, 2 | 2017-07-18 |
Thiazole orexin receptor antagonists Grant 9,695,163 - Liverton , et al. July 4, 2 | 2017-07-04 |
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114056 - Mitchell; Helen ;   et al. | 2017-04-27 |
Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators App 20160229813 - Kuduk; Scott D. ;   et al. | 2016-08-11 |
Thiazole Orexin Receptor Antagonists App 20160185768 - LIVERTON; NIGEL ;   et al. | 2016-06-30 |
Oxazole Orexin Receptor Antagonists App 20160176858 - LIVERTON; NIGEL ;   et al. | 2016-06-23 |
1,3 substituted azetidine PDE10 inhibitors Grant 9,365,562 - Cox , et al. June 14, 2 | 2016-06-14 |
Cyclopropyl imidazopyridine PDE10 inhibitors Grant 9,359,348 - Kuduk , et al. June 7, 2 | 2016-06-07 |
N-linked lactam M1 receptor positive allosteric mogulators Grant 9,206,200 - Kuduk , et al. December 8, 2 | 2015-12-08 |
Cyclopropyl Imidazopyridine Pde10 Inhibitors App 20150307488 - Kuduk; Scott D. ;   et al. | 2015-10-29 |
Aminomethyl biaryl benzotriazole derivatives Grant 9,139,576 - Beshore , et al. September 22, 2 | 2015-09-22 |
Ether benzotriazole derivatives Grant 8,975,286 - Dudkin , et al. March 10, 2 | 2015-03-10 |
N-linked Lactam M1 Receptor Positive Allosteric Modulators App 20150065498 - Kuduk; Scott D. ;   et al. | 2015-03-05 |
Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators App 20150031713 - Kuduk; Scott D. ;   et al. | 2015-01-29 |
Quinolinone-pyrazolone M1 receptor positive allosteric modulators Grant 8,895,580 - Beshore , et al. November 25, 2 | 2014-11-25 |
Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators Grant 8,883,810 - Kuduk , et al. November 11, 2 | 2014-11-11 |
Naphthalene carboxamide M1 receptor positive allosteric modulators Grant 8,883,850 - Beshore , et al. November 11, 2 | 2014-11-11 |
1,3 Substituted Azetidine Pde10 Inhibitors App 20140256708 - Cox; Christopher D. ;   et al. | 2014-09-11 |
Cyclohexene benzotriazole derivatives Grant 8,785,482 - Beshore , et al. July 22, 2 | 2014-07-22 |
Ether benzotriazole derivatives Grant 8,785,481 - Beshore , et al. July 22, 2 | 2014-07-22 |
Isoindolone M1 receptor positive allosteric modulators Grant 8,697,690 - Beshore , et al. April 15, 2 | 2014-04-15 |
Cyclohexene Benzotriazole Derivatives App 20140088150 - Beshore; Douglas C. ;   et al. | 2014-03-27 |
Alhydroxymethyl Biaryl Benzotriazole Derivatives App 20140088151 - Beshore; Douglas C. ;   et al. | 2014-03-27 |
Aminomethyl Biaryl Benzotriazole Derivatives App 20140066443 - Beshore; Douglas C. ;   et al. | 2014-03-06 |
Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators Grant 8,653,079 - Beshore , et al. February 18, 2 | 2014-02-18 |
Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators App 20140005182 - Kuduk; Scott D. ;   et al. | 2014-01-02 |
Aryl methyl benzoquinazolinine M1 receptor positive allosteric modulators Grant 8,557,832 - Kuduk , et al. October 15, 2 | 2013-10-15 |
Heterocyclic quinolizine derived M1 receptor positive allosteric modulators Grant 8,507,494 - Beshore , et al. August 13, 2 | 2013-08-13 |
Pyrazolo [4,3-c] cinnolin-3-one M1 receptor positive allosteric modulators Grant 8,486,946 - Beshore , et al. July 16, 2 | 2013-07-16 |
Isoindolone M1 Receptor Positive Allosteric Modulators App 20130109686 - Beshore; Douglas C. ;   et al. | 2013-05-02 |
Pyrazolo [4,3-c] Cinnolin-3-one M1 Receptor Positive Allosteric Modulators App 20130102599 - Beshore; Douglas C. ;   et al. | 2013-04-25 |
Heterocyclic-fused pyrazolo[4,3-c]pyridin-3-one M1 receptor positive allosteric modulators Grant 8,426,438 - Beshore , et al. April 23, 2 | 2013-04-23 |
Naphthalene Carboxamide M1 Receptor Positive Allosteric Modulators App 20130059860 - Beshore; Douglas C. ;   et al. | 2013-03-07 |
Aminobenzoquinazolinone M1 receptor positive allosteric modulators Grant 8,383,638 - Kuduk , et al. February 26, 2 | 2013-02-26 |
Heterocyclic Quinolizine Derived M1 Receptor Positive Allosteric Modulators App 20130040959 - Beshore; Douglas C. ;   et al. | 2013-02-14 |
Heterocyclic fused cinnoline M1 receptor positive allosteric modulators Grant 8,293,744 - Kuduk , et al. October 23, 2 | 2012-10-23 |
Quinolinone-pyrazolone M1 Receptor Positive Allosteric Modulators App 20120196845 - Beshore; Douglas C. ;   et al. | 2012-08-02 |
Heterocyclic-Fused Pyrazolo[4,3-c] Pyridin-3-One M1 Receptor Positive Allosteric Modulators App 20120178760 - Beshore; Douglas C. ;   et al. | 2012-07-12 |
Ether Benzotriazole Derivatives App 20120149677 - Dudkin; Vadim Y. ;   et al. | 2012-06-14 |
Ether Benzotriazole Derivatives App 20120135977 - Beshore; Douglas C. ;   et al. | 2012-05-31 |
Heterocyclic Fused Cinnoline M1 Receptor Positive Allosteric Modulators App 20120040978 - Kuduk; Scott D. ;   et al. | 2012-02-16 |
PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS App 20110301167 - Beshore; Douglas C. ;   et al. | 2011-12-08 |
Fused pyridone M1 receptor positive allosteric modulators Grant 8,022,215 - Beshore , et al. September 20, 2 | 2011-09-20 |
Aryl Methyl Benzoquinazolinine M1 Receptor Positive Allosteric Modulators App 20110224198 - Kuduk; Scott D. ;   et al. | 2011-09-15 |
Tyrosine kinase inhibitors Grant 8,008,295 - Dinsmore , et al. August 30, 2 | 2011-08-30 |
Potassium channel inhibitors Grant 7,879,839 - Dinsmore , et al. February 1, 2 | 2011-02-01 |
Fused Pyridone M1 Receptor Positive Allosteric Modulators App 20100324088 - Beshore; Douglas C. ;   et al. | 2010-12-23 |
Isoquinoline potassium channel inhibitors Grant 7,763,614 - Isaacs , et al. July 27, 2 | 2010-07-27 |
Tyrosine Kinase Inhibitors App 20100041652 - Dinsmore; Christopher J. ;   et al. | 2010-02-18 |
Tyrosine kinase inhibitors App 20090186871 - Dinsmore; Christopher J. ;   et al. | 2009-07-23 |
Tyrosine kinase inhibitors Grant 7,560,546 - Dinsmore , et al. July 14, 2 | 2009-07-14 |
Potassium Channel Inhibitors App 20080090794 - Dinsmore; Christoph J. ;   et al. | 2008-04-17 |
Tyrosine kinase inhibitors App 20080008708 - Dinsmore; Christopher J. ;   et al. | 2008-01-10 |
Isoquinoline potassium channel inhibitors App 20070054892 - Isaacs; Richard ;   et al. | 2007-03-08 |
Tyrosine kinase inhibitors App 20060128783 - Dinsmore; Christopher J. ;   et al. | 2006-06-15 |
Tyrosine kinase inhibitors App 20050261496 - Dinsmore, Christopher J. ;   et al. | 2005-11-24 |
Inhibitors of prenyl-protein transferase Grant 6,441,017 - Bell , et al. August 27, 2 | 2002-08-27 |
Inhibitors of prenyl-protein transferase Grant 6,358,985 - Anthony , et al. March 19, 2 | 2002-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.